openPR Logo
Press release

Excessive Growth Opportunities Estimated to be Experienced by Vitreous Tamponades Market During 2020

09-25-2017 09:43 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Excessive Growth Opportunities Estimated to be Experienced

The introduction of new products and new technologies is another key growth model that leading players in this market are exploring. Strategic mergers and acquisitions for the expansion of distributor base are on the growth plans of leading companies in the global vitreous tamponades market, adds TMR.

Declining Rate of Complications due to Diabetes in U.S. Challenges Market Growth

The major factor driving the global vitreous tamponades market is the increasing incidence of retinal detachment, macular pucker, and other ophthalmic conditions. Vitreous tamponades are used for the treatment of several vitreoretinal disorders such as retinal detachment, age-related macular degeneration, diabetic retinopathy, and vitreous hemorrhage. For instance, as per the International Diabetes Federation, almost 300 million individuals were affected with diabetes worldwide in 2010 and this number is expected to reach 438 million by 2030. A rising geriatric population that is susceptible to retinal disorders is also favoring the growth of the vitreous tamponades market.

View and Download TOC of Vitreous Tamponades Market Research Report@ https://www.transparencymarketresearch.com/report-toc/4233

“The commoditization of the vitreous tamponades market in Asia Pacific, Europe, and Rest of the World is challenging the growth of this market”, says a TMR analyst. Increasing demand for tamponades that are effective in the long-term and the price war that has spurred between local manufacturers and global vendors is adversely affecting industry revenue.

The decline in the incidence of diabetic retinopathy in North America is also slowing the growth of the global vitreous tamponades market. As per the American Diabetes Association, the complications arising due to diabetes have significantly reduced between 1990 and 2010 in the U.S. Moreover, the increasing number of awareness programs for routine eye examination carried out by governments and the World Health Organization has resulted in a considerable decline in the rate of proliferative diabetic retinopathy.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233

Gaseous Tamponades to Display Significant Growth Rate in Future

Liquid tamponades dominated the global vitreous tamponades market on the basis of product type in 2013, the segment held more than 49% of the overall market in the same year. The large market share of liquid tamponades is attributed to their extensive use in Europe and Asia for the treatment of retinal detachments with multiple breaks, proliferative diabetic retinopathy, giant tears, and proliferative vitreoretinopathy. Silicone oil liquid tamponades will register the fastest growth during the report’s forecast period. However, a high cost of silicone oil tamponades and their high chances of emulsification in the eye due to their low viscosity and surface tension are likely to limit the uptake of these tamponades. Perfluorocarbons liquid tamponades will display a constant growth rate as they are largely used for reattaching giant retinal tears.

On the other hand, gaseous tamponades will display the highest growth rate due to their low risk of emulsification, ease of use, and reduced cost.

The global vitreous tamponades market is expected to reach a valuation of US$77.5 mn by 2020.

The competitive landscape of the global vitreous tamponades market is highly fragmented due to the presence of numerous local and global players, states Transparency Market Research (TMR). Some of the top players operating in the global vitreous tamponades market are Carl Zeiss Meditec AG, Alcon Inc., Fluron GmbH, Valeant Pharmaceuticals International Inc., and Dutch Ophthalmic Research Center B.V.

“Expansion of distribution networks and distributor subsidiaries is the strategy top companies in this market are adopting to augment sales,” points out a TMR analyst. For example, Alchimia Srl’s sales in the U.S. and Latin America are handled by Oftalmedia LLC, whereas its sales in other regions are handled by its Italy-based subsidiary BBS Srl.

Buy Full Vitreous Tamponades Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=4233<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Excessive Growth Opportunities Estimated to be Experienced by Vitreous Tamponades Market During 2020 here

News-ID: 736424 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end